投资者关系
Information disclosure Stock Information Presentation Materials and Newsletter Corporate Governance Investor Calendar Investor Enquiries
Introduction of TaurusWave® Lithotripsy Valvuloplasty System and FIM Clinical Trial
2021-11-19 22:39:13

全球领先“非醛交联”经导管主动2

上一篇：Peijia Medical’s 2021 Annual Results Presentation Materials
下一篇：Future of TAVR for AR JenaValve TrilogyTM TAVR System
Top